Cingulate Inc.
NASDAQ:CINGBiotechnology
-$0.05 today
- Market cap
- $76.46M
- Beta
- -0.91
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$5.10
Volume 0.95M
Average 0.46M
CING Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Cingulate Inc.NASDAQ: CING
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 218.1% from a year ago
Total equity stood at $18.86M at the end of Q1 FY2026, up 218.1% from a year earlier and up 651.9% from the prior quarter. Over 3 fiscal years it compounded at -13.5% a year.
Context
- Total equity amounted to 61.1% of total assets at the end of Q1 FY2026, up 13.6 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +218.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 2.51M USD
- Year-over-year change
- -66.3%
- 4-year CAGR
- -41.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.51M | -66.3% |
| FY2024 | 2024-12-31 | 7.46M | +208.5% |
| FY2023 | 2023-12-31 | (6.87M) | -277.0% |
| FY2022 | 2022-12-31 | 3.88M | -81.4% |
| FY2021 | 2021-12-31 | 20.84M | — |
Total Equity vs competitors
How CING compares with its peers on the latest reported figures
- CING's Mar 2026 total equity of $18.86M is the highest of the 2 companies compared; the peer median is $9.18M.
- Its year-over-year change of +218.1% is the lowest of 2, against a peer median of +691.9%.
- Total equity amounts to 61.1% of total assets for CING, versus a peer median of 84.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $18.86M | +218.1% | -13.5% | 61.1% | |
| Mar 2026 | $9.18M | +691.9% | +28.5% | 84.5% | |
| Peer median (excluding CING) | $9.18M | +691.9% | +28.5% | 84.5% | |
Competitors are the stored peer set for CING. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16.49M | 5.36M | 52.42K | 12.21M | 10.95M |
| Short-term Investments | 933 | 0 | 0 | 0 | 0 |
| Net Receivables | 690.25K | 234.43K | 14.62K | 26.33K | 8.01K |
| Inventory | 0 | 100.34K | 0 | 0 | 0 |
| Other Current Assets | 1.7M | 1.64M | 490.86K | 368.29K | 80.08K |
| Total Current Assets | 18.88M | 7.87M | 578.59K | 12.66M | 12.01M |
| Property, Plant & Equipment (Net) | 4M | 3.54M | 2.91M | 2.2M | 3.07M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.36B | 5.91B | 0 | 0 | 0 |
| Other Non-current Assets | (1.36B) | (5.91B) | 0 | 0 | 0 |
| Total Non-current Assets | 4M | 3.54M | 2.91M | 2.2M | 3.07M |
| Total Assets | 22.89M | 11.41M | 3.49M | 14.86M | 15.07M |
| Account Payables | 264.69K | 762.36K | 5.2M | 1.27M | 2.04M |
| Short-term Debt | 310.69K | 5M | 3M | 2.53M | 6.3M |
| Tax Payables | 0 | 0 | 120.57K | 200K | 0 |
| Deferred Revenue | 601.3K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (336.67K) | 719.01K | 593.02K | 355.48K | 455.18K |
| Total Current Liabilities | 1.18M | 7.01M | 10.23M | 4.97M | 10.31M |
| Long-term Debt | 0 | 0 | 0 | 2.44M | 1.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 866.04K | 510.24K | 135.1K | 2.44M | 2.25M |
| Total Liabilities | 2.04M | 7.52M | 10.36M | 7.41M | 12.56M |
| Common Stock | 1.13K | 61 | 10 | 340 | 725 |
| Retained Earnings | (51.73M) | (69.41M) | (92.94M) | (108.49M) | (132.38M) |
| Accumulated OCI | 165 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 20.84M | 3.88M | (6.87M) | 7.46M | 2.51M |
| Total Debt | 1.19M | 5.87M | 3.51M | 5.1M | 8.79M |
| Net Debt | (15.3M) | 509.77K | 3.46M | (7.11M) | (2.17M) |
Cingulate Inc.
NASDAQ:CING
Intrinsic Alpha fair value
Locked
Current Price
$5.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.